Description
Olaparix helps to treatment in patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer with a various type of inherited (germline) or acquired (somatic) abnormal BRCA gene. This is use in patients who received complete or partial treatment with platinum-based cancer medicines.
Olaparix, is drugs forms, in treating the women who suffering from ovarian and breast cancer. Olaparib is a poly (ADP-ribose) polymerase (PARP) inhibitor that is primarily indicated in treating ovarian and breast cancer
Reviews
There are no reviews yet.